Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Biosion, Inc.'s stake in Aclaris Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Biosion, Inc.'s stake in Aclaris Therapeutics, Inc. fell to 4.70%, 7,521,300 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 7,521,300
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Biosion, Inc. | 4.70% | 7,521,300 |
| Bonita Biotech (HK) Ltd | 4.70% | 7,521,300 |
Source
Download original · View original at SEC
Related
- Aclaris Therapeutics, Inc.
- Biosion, Inc.
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G/A · Biosion, Inc. · Jan 9, 2026
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Schiff Andrew N · Jun 8, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026